Ecotec by Marchi & Fildi Yarn to Partake in Filo Milano
Marchi & Fildi, developers of cotton-based yarns for the textile industry that are making latest innovations with Ecotec smart cotton, will present its new collection and achievements in the field of yarns at Filo Milano, the international B2B exhibition for yarns and fibres, which will be held from February 21 and 22, 2018, in Italy, in booth D5-D7.
The company has announced a €2 million investment in highly specialised process technology always aiming at improving Ecotec process and its yarn product range.
On top of this, Ecotec is also widening its portfolio range, thanks to the introduction of special yarns with counts and styles designed for knitwear production. Ecotec Moulinè and micromoulinè yarns offer amazing colour effects and precious touch. Ecotec cable yarn have soft twists for full body hand, authentic touch and with amazing colour cards.
The Ecotec collection will include an exclusive seasonal range of Ecotec fabrics created by partners that include Ledatex, 3C Company S.r.l., O’Jersey, Nalya, and Sidònios Knitwear. And longstanding accredited partners include Lanificio COMATEX, Euromaglia Srl, RDD, Manifattura CBM, Tessuti & Tessuti srl, and Tintex Textiles.
This season, Ecotec will present an exclusive range of smart textile design solutions from the Marchi & Fildi research and development centre in cooperation with the UK expert textile trend forecaster, Sandy Mac Lennan. It is called Ecotec Innovation, and it is an inspiring line developed with the clear goal of highlighting Ecotec uniqueness with solutions that are real avant-garde in fashion trends.
Ecotec smart cotton by Marchi & Fildi is the first Made in Italy material obtained through an exclusive, fully traceable and certified production process that transforms 100 per cent cotton yarn already-dyed textile cuts with remarkable efficiency in terms of water, energy, and CO2 savings.
Looking for chemical products? Let suppliers reach out to you!
2026-07-21
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Forced to "cut"! South Korean Petrochemical Giants Forced to Cut Production by 25%
-
Toray Supplies Reverse Osmosis Membranes to Saudi Arabian Desalination Plant
-
Huntsman Partners with Wobatek to Expand TPU Distribution
-
Avril Group to Acquire Champlor Renewables from Valtris
-
Axplora Expands Indian Market: €6.5 Million to Expand API Manufacturing in Vizag
-
Another Strategic Move! DuPont Launches a New Specialty Lubricants Project in Zhangjiagang
-
Sinopec Builds 146 Hydrogen Refueling Stations, Ranking Among the World’s Largest Operators
-
LG Chem and Enilive Break Ground on South Korea’s First HVO and SAF Production Facility
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
Indonesia Forges a Green Future for Its Highly Dynamic Packaging & Automotive Industries
Recommend Reading
-
IMCD to Acquire Tillmanns
-
¥20 Million Investment Lands in Qingdao: China and Japan Join Hands to Build High-Active Zinc Oxide Production Base
-
Saint-Gobain Makes Construction Chemicals Acquisitions in Canada, Italy, and Peru
-
DSM-Firmenich to Invest €70 Million to Expand Its India Presence
-
Breakup! Vland Biotech and Evonik Part Ways as GHS Joint Venture Falls Short of Expectations
-
Indonesia Plans B50 Biodiesel Mandate for 2026 Palm Oil Usage May Hit 19 Million Kiloliters
-
Sumitomo Chemical Unveils Breakthrough Pilot Plant for Direct Propylene from Ethanol Green Hydrogen as Byproduct
-
Kuraray H1 Net Profit Plunges 54 Percent Sales Fall to 399.96 Billion Yen Price Hikes Announced for GENESTAR
-
Wanhua Chemical Boosts TDI Capacity to 1.44 Million Tons New 360000-Ton Plant Launches Amid Global Maintenance Cycle
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny